Gulf International Bank UK Ltd Sells 75 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Gulf International Bank UK Ltd trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,768 shares of the biotechnology company’s stock after selling 75 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Axon Enterprise were worth $1,697,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. ING Groep NV boosted its stake in Axon Enterprise by 9.3% in the 4th quarter. ING Groep NV now owns 9,643 shares of the biotechnology company’s stock worth $2,491,000 after purchasing an additional 821 shares in the last quarter. Avantax Advisory Services Inc. grew its holdings in shares of Axon Enterprise by 0.8% during the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after buying an additional 40 shares during the last quarter. GSA Capital Partners LLP bought a new stake in shares of Axon Enterprise during the first quarter valued at approximately $931,000. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Axon Enterprise by 14.8% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock worth $53,307,000 after acquiring an additional 22,013 shares during the last quarter. Finally, Apollon Wealth Management LLC bought a new position in Axon Enterprise in the 4th quarter valued at approximately $234,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of AXON stock traded up $10.38 on Thursday, reaching $359.62. The company’s stock had a trading volume of 475,687 shares, compared to its average volume of 516,728. The company has a market capitalization of $27.14 billion, a price-to-earnings ratio of 104.46, a price-to-earnings-growth ratio of 6.59 and a beta of 0.95. The stock’s fifty day simple moving average is $297.44 and its 200-day simple moving average is $295.00. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 1 year low of $189.12 and a 1 year high of $367.95.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. During the same period in the previous year, the firm posted $0.80 EPS. The business’s quarterly revenue was up 34.5% on a year-over-year basis. Analysts forecast that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Robert W. Baird increased their price objective on Axon Enterprise from $355.00 to $360.00 and gave the company an “outperform” rating in a research report on Wednesday. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday. Barclays boosted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday. JPMorgan Chase & Co. raised their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. Finally, Craig Hallum raised their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $348.08.

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 478 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $286.04, for a total transaction of $136,727.12. Following the transaction, the director now owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Julie A. Cullivan sold 993 shares of the business’s stock in a transaction on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the transaction, the director now owns 4,553 shares in the company, valued at approximately $1,282,671.16. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 478 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total value of $136,727.12. Following the completion of the transaction, the director now directly owns 5,546 shares in the company, valued at approximately $1,586,377.84. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.